ArticleVaccines2022

Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes.

Ricardo Serna-Muñoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.